Search | Webyourself Social Media Platform

Shubham Wemarket added blog Health
2024-08-14 08:27:52 -

Panitumumab Market Analysis, Key Players, Share Dynamic Demand and Consumption by 2024 to 2034
Panitumumab is a monoclonal antibody used primarily in the treatment of metastatic colorectal cancer. It targets the epidermal growth factor receptor (EGFR), which plays a critical role in the growth and survival of cancer cells. The market for Panitumumab is part of the broader oncology and biologics markets. The Panitumumab market is expected to grow at a compound annual growth rate (CAGR)...

0 Comments 0 Shares 455 Views 0 Reviews

Please log in to like, share and comment!
Shubham Wemarket added blog Other
2024-08-27 09:28:35 -

Panitumumab Market Analysis, Type, Size, Trends, Key Players and Forecast 2024 to 2034
Panitumumab is a fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It is used in the treatment of wild-type RAS metastatic colorectal cancer (mCRC). The Panitumumab Market is growing due to increasing incidences of colorectal cancer, rising awareness about monoclonal antibody therapies, and advancements in personalized medicine. The...

0 Comments 0 Shares 345 Views 0 Reviews

Please log in to like, share and comment!